Pre-test probability, clinical likelihood, and risk assessment of CAD - Dr. Ahmed Bendary

Пікірлер: 13

  • @abdullahmolda8932
    @abdullahmolda8932 Жыл бұрын

    Very good presentation prof

  • @mohammadhalim9584
    @mohammadhalim95842 жыл бұрын

    Amazing 👏

  • @mahmoud27898
    @mahmoud278982 жыл бұрын

    Thanks

  • @mabroukahouderi5667
    @mabroukahouderi5667 Жыл бұрын

    بارك الله فيك يا دكتور ، عرض جميل ورائع

  • @dr.moahmedsaid9469
    @dr.moahmedsaid94693 жыл бұрын

    Great awesome creative as usual Prof Ahmed Bendary ❤️

  • @wessamahmed6325
    @wessamahmed63253 жыл бұрын

    Great as usual Keep up the good work Dr Bendary

  • @tofysoliman7494
    @tofysoliman74943 жыл бұрын

    Very interesting and beatiful lecture and presentation

  • @pipohassanful
    @pipohassanful3 жыл бұрын

    Great doctor

  • @mohammednabil9407
    @mohammednabil94073 жыл бұрын

    جزاكم الله خيرا

  • @drspy88
    @drspy882 жыл бұрын

    محاضرة ممتازة

  • @islamali2560
    @islamali25603 жыл бұрын

    Thanks , nice lecture 🌹

  • @tofysoliman7494
    @tofysoliman74943 жыл бұрын

    there is a very important point the PTP is based on low risk countries while Egypt is a high risk country acccording to prevention guidelines ,,,,So 2013 PTP is more accurate in Egypt :However, it should be noted that the PTPs presented in Table 5 (as well as the PTP table in the previous version of the Guidelines) are based mainly on patients from countries with low CVD risk, and may vary between regions and countries.